✦ LIBER ✦

Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma

✍ Scribed by Ladetto, M; Zallio, F; Vallet, S; Ricca, I; Cuttica, A; Caracciolo, D; Corradini, P; Astolfi, M; Sametti, S; Volpato, F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Absorbed dose and biologically effective

✍ C. Chiesa; F. Botta; A. Coliva; M. Maccauro; L. Devizzi; A. Guidetti; C. Carlo-S 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 265 KB

Safety and feasibility of CHOP/rituximab

✍ Heß, G; Flohr, T; Huber, C; Kolbe, K; Derigs, H-G; Fischer, T 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB

Neutropenic infections in 100 patients w

✍ Seropian, S; Nadkarni, R; Jillella, A P; Salloum, E; Burtness, B; Hu, G L; Zelte 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 56 KB

Randomized trial of peripheral blood pro

✍ Kanteti, R; Miller, K B; McCann, J C; Roitman, D; Morelli, J; Hurley, C; Berkman 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Phase II study of a salvage regimen usin

✍ Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

High-dose chemotherapy and peripheral bl

✍ Weaver, C H; Schwartzberg, L; Zhen, B; Mangum, M; Leff, R; Tauer, K; Rosenberg, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB